|
|
|
|
|
|
|
|
|
/ December 11: eyeforpharma Awards 2019
/ |
|
Philadelphia, PA |
|
/ December 11¬–12: Pharmaceutical Drug Pricing Strategies Summit
/ |
|
Washington, DC |
|
Washington, DC |
|
/ December 11: Clinical Trial Financial Management
/ |
|
Philadelphia, PA |
|
/ March 8-11, 2020: Pharma Forum 2020
/ |
|
New York City, NY |
|
/ March 18–19 2020: World Pharma Pricing Market Access & Evidence Congress
/ |
|
Amsterdam, The Netherlands |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress
/ |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020
/ |
|
Barcelona, Spain |
 |
|
| |
|
|
|
|
|
|
|
|
|
| |
| Industry update |
| // Abbott Laboratories (Chicago, IL) announced that Miles White will be stepping down as CEO, following a 21-year tenure. The company has appointed Robert Ford to succeed White in the role on March 31, 2020. Ford currently serves as Abbott’s President and Chief Operating Officer.
//
Kite Pharma (Los Angeles, CA) appointed Charles Calderaro as Global Head of Technical Operations and Ken Takeshita as Global Head of Clinical Development.
//
Arrakis Therapeutics (Waltham, MA) appointed Katrine Bosley as Chairman of its Board of Directors.
//
Biotech company Akelos (New York, NY) appointed former Pfizer executive Thomas G. Heffner, Ph.D., as a Strategic Advisor.
|
|
|
|
|
|
|
|
|
